TPG Capital Acquires Majority Stake in Confluent Medical

January 5, 2022

TPG Capital has made a majority investment in Confluent Medical Technologies, a materials-science-led developer and manufacturer of complex implantable medical devices and delivery systems. Existing investor Ampersand Capital Partners retains a substantial minority stake; the investment will provide capital and expertise to expand Confluent's manufacturing capabilities and support growth into new technical areas and end markets.

Buyers
TPG Capital
Targets
Confluent Medical Technologies
Industry
Medical Devices
Location
Arizona, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.